SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-19-044922
Filing Date
2019-09-17
Accepted
2019-09-17 16:54:02
Documents
2
Group Members
PETER KOLCHINSKY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tv529598_sc13d.htm SC 13D 57326
2 JOINT FILING AGREEMENT tv529598_ex99-1.htm EX-99.1 5330
  Complete submission text file 0001144204-19-044922.txt   64221
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91126 | Film No.: 191097577
SIC: 2834 Pharmaceutical Preparations